These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28664407)

  • 21. The cytoprotective role of autophagy in puromycin aminonucleoside treated human podocytes.
    Kang YL; Saleem MA; Chan KW; Yung BY; Law HK
    Biochem Biophys Res Commun; 2014 Jan; 443(2):628-34. PubMed ID: 24333414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Podocyte injury is suppressed by 1,25-dihydroxyvitamin D via modulation of transforming growth factor-beta 1/bone morphogenetic protein-7 signalling in puromycin aminonucleoside nephropathy rats.
    Xiao HQ; Shi W; Liu SX; Zhang B; Xu LX; Liang XL; Liang YZ
    Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):682-9. PubMed ID: 19594554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GLEPP1 receptor tyrosine phosphatase (Ptpro) in rat PAN nephrosis. A marker of acute podocyte injury.
    Kim YH; Goyal M; Wharram B; Wiggins J; Kershaw D; Wiggins R
    Nephron; 2002 Apr; 90(4):471-6. PubMed ID: 11961407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Semi-automated quantitative image analysis of podocyte desmin immunoreactivity as a sensitive marker for acute glomerular damage in the rat puromycin aminonucleoside nephrosis (PAN) model.
    Herrmann A; Tozzo E; Funk J
    Exp Toxicol Pathol; 2012 Jan; 64(1-2):45-9. PubMed ID: 20591637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
    Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
    J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bone mesenchymal stem cell transplantation repairs glomerular podocytes in rats with puromycin aminonucleoside-induced nephrosis].
    Yang HD; Dong C; Guan FJ; Gao LL; Zhao T; Feng BF
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jun; 12(6):483-7. PubMed ID: 20540862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravital and Kidney Slice Imaging of Podocyte Membrane Dynamics.
    Brähler S; Yu H; Suleiman H; Krishnan GM; Saunders BT; Kopp JB; Miner JH; Zinselmeyer BH; Shaw AS
    J Am Soc Nephrol; 2016 Nov; 27(11):3285-3290. PubMed ID: 27036737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in glomerular epithelial cells induced by FGF2 and FGF2 neutralizing antibody in puromycin aminonucleoside nephropathy.
    Sasaki T; Jyo Y; Tanda N; Kawakami Y; Nohno T; Tamai H; Osawa G
    Kidney Int; 1997 Jan; 51(1):301-9. PubMed ID: 8995747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Differential expressions of miRNAs in kidney in puromycin aminonucleoside nephropathy model and intervened effects of Leizhi capsule].
    Sun W; Li CQ; Chen JH; Shao JD; Zhou D; Zhang L; Gao K
    Zhongguo Zhong Yao Za Zhi; 2013 Jan; 38(1):81-90. PubMed ID: 23596882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy.
    Floege J; Kriz W; Schulze M; Susani M; Kerjaschki D; Mooney A; Couser WG; Koch KM
    J Clin Invest; 1995 Dec; 96(6):2809-19. PubMed ID: 8675651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A high-powered view of the filtration barrier.
    Peti-Peterdi J; Sipos A
    J Am Soc Nephrol; 2010 Nov; 21(11):1835-41. PubMed ID: 20576805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Podocyte Wnt/ß-catenin pathway is activated by integrin-linked kinase in clinical and experimental focal segmental glomerulosclerosis.
    Naves MA; Requião-Moura LR; Soares MF; Silva-Júnior JA; Mastroianni-Kirsztajn G; Teixeira VP
    J Nephrol; 2012; 25(3):401-9. PubMed ID: 21928230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
    Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
    Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesenchymal stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in adriamycin-induced nephropathy.
    Zoja C; Garcia PB; Rota C; Conti S; Gagliardini E; Corna D; Zanchi C; Bigini P; Benigni A; Remuzzi G; Morigi M
    Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1370-81. PubMed ID: 22952284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Puromycin induces reversible proteinuric injury in transgenic mice expressing cyclooxygenase-2 in podocytes.
    Jo YI; Cheng H; Wang S; Moeckel GW; Harris RC
    Nephron Exp Nephrol; 2007; 107(3):e87-94. PubMed ID: 17890881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glomerular function and morphology in puromycin aminonucleoside nephropathy in rats.
    Löwenborg EK; Jaremko G; Berg UB
    Nephrol Dial Transplant; 2000 Oct; 15(10):1547-55. PubMed ID: 11007821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling.
    Shibata S; Nagase M; Fujita T
    J Am Soc Nephrol; 2006 Mar; 17(3):754-64. PubMed ID: 16452496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glomerular filtrate affects the dynamics of podocyte detachment in a model of diffuse toxic podocytopathy.
    Saga N; Sakamoto K; Matsusaka T; Nagata M
    Kidney Int; 2021 May; 99(5):1149-1161. PubMed ID: 33582108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies.
    Zeng C; Fan Y; Wu J; Shi S; Chen Z; Zhong Y; Zhang C; Zen K; Liu Z
    J Pathol; 2014 Oct; 234(2):203-13. PubMed ID: 24870816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synaptic vesicle protein 2B is expressed in podocyte, and its expression is altered in proteinuric glomeruli.
    Miyauchi N; Saito A; Karasawa T; Harita Y; Suzuki K; Koike H; Han GD; Shimizu F; Kawachi H
    J Am Soc Nephrol; 2006 Oct; 17(10):2748-59. PubMed ID: 16943307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.